Dansk English

Kalundborg Bioenergi

In co-operation with Ørsted (former DONG) Bigadan established a full-scale biogas plant which handles waste products from the insulin and enzyme production at Novo Nordisk and Novozymes. Construction commenced in the spring of 2017, and the biogas plant was commissioned in the spring of 2018, where the production was equivalent to the annual natural gas consumption of 5.000 households.

Bigadan is now the sole owner of the plant.

Plant facts

  • Location Kalundborg
  • Supplier Bigadan A/S
  • Client Kalundborg Bioenergi A/S
  • Scope of delivery Turnkey biogas plant incl gas upgrading plant
  • Year of delivery 2018
  • Capacity 300.000 t/year
  • Biomass Waste products from insulin and enzyme production
  • Biogas capacity 8 million m³/a
  • Biogas utilization Gas upgrading to natural gas and injection into natural gas grid